Aerobic Endurance Clinical Trial
Official title:
Effects of Photobiomodulation Therapy in Aerobic Training and Detraining in Humans
In last years it has been demonstrated that photobiomodulation therapy (PBMT) has ergogenic
effects. However some key aspects, such as the potentially beneficial effects of PBMT during
the detraining period still remain unknown.
Therefore, the aim of this project is to evaluate the effects of PBMT applied before and
after aerobic training sessions and during the detraining period.
It will be carried out a randomized, triple-blind, placebo-controlled trial.
Seventy-two volunteers will be randomly allocated to four experimental groups:
1. PBMT before and after the aerobic training sessions and PBMT during the detraining
period;
2. PBMT before and after the aerobic training sessions and placebo during the detraining
period;
3. Placebo before and after the aerobic training sessions and PBMT during the detraining
period;
4. Placebo before and after the aerobic training sessions and placebo during the detraining
period .
The individuals randomly allocated to the different groups will be subjected to 12
consecutive weeks of aerobic training performed on a treadmill 3 times a week on
non-consecutive days. Each training session will last 30 minutes, with an intensity ranging
from 85 to 90% maximum heart rate. PBMT or placebo will be applied before and after each
training session. After the 12-week training period, the volunteers will receive the
application of PBMT or placebo depending on the group to which they are allocated for 4 weeks
(3 times a week) without training.
The data will be collected by a blind assessor. It will be analyzed time of the exercise
(time until exhaustion), maximum oxygen consumption in absolute and relative values in
relation to body mass (VO2max). Moreover, it will be evaluated the body composition. The
evaluations will be performed before starting the protocol (baseline) and after 4, 8, and 12
weeks of training. They will also be performed after 4 weeks without training (detraining
period).
The findings will be tested for their normality using the Shapiro-Wilk test. Parametric data
will be expressed as mean and standard deviation and nonparametric data as median and
respective upper and lower limits. Parametric data will be analyzed by two-way repeated
measures analysis of variance (ANOVA; time versus experimental group) with post-hoc
Bonferroni correction. Non-parametric data will be analyzed using the Friedman test and,
secondarily, the Wilcoxon signed-rank test. Data will be analyzed in terms of both their
absolute values and their relationship to the percentage change based on the values
established in the baseline tests. The significance level will be set at p<0.05.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT06165523 -
Kefir Versus Milk on Time-Trial Performance in Masters Athletes
|
N/A | |
| Recruiting |
NCT06054607 -
Effect of Short-chain Fatty Acids on Aerobic Endurance
|
N/A |